Hematology

Lydia Scarfò discusses types of leukaemia, current treatment approaches, recent advances, and future possibilities.

Rafael Fonseca, Consultant, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA

Paolo Gallipoli, Clinical Reader, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London joins the podcast to discuss the biology, onset, and treatment of myeloid leukaemias.

Diu Nguyen, Lecturer and Group Leader at the Centre for Haemato-Oncology, Barts Cancer Institute, joins the podcast to discuss breakthroughs in acute myeloid leukaemia (AML) research

John Riches, Clinical Reader in Cancer Immunometabolism, Barts Cancer Institute; Honorary Consultant Haemato-oncologist, Barts Health NHS Trust, London, UK, discusses how metabolism could conquer lymphoma.

Shaji Kumar, Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

Take look back at Jonathan Sackier’s highlights from the Hema Now podcast so far, exploring CAR-T therapies, bispecific antibodies and more.

Xavier Leleu, Head of the Department of Hematology at Centre Hospitalier Universitaire (CHU), Université de Poitiers, France